Raccagni Angelo Roberto, Passini Flavia, Diotallevi Sara, Lolatto Riccardo, Bruzzesi Elena, Piromalli Girolamo, Candela Caterina, Castagna Antonella, Nozza Silvia
Infectious Diseases Unit, Vita-Salute San Raffaele University, Milan, Italy.
Infectious Diseases Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
J Acquir Immune Defic Syndr. 2025 Jan 1;98(1):37-40. doi: 10.1097/QAI.0000000000003544.
The aim of this study is to assess the acceptability of HIV preexposure prophylaxis (PrEP) among individuals eligible for prophylaxis.
Retrospective study of individuals receiving their first HIV test at the Infectious Diseases Unit of IRCCS San Raffaele Scientific Institute, Milan, Italy.
People (1) who received their first HIV test (baseline date) between January 2018 (availability of PrEP in Italy) and December 2023 (data lock) and (2) with an indication for PrEP based on condomless sex were included; those already on PrEP were excluded. Individuals with a negative HIV test result were offered PrEP counseling and prescription according to guidelines. Characteristics of people who accepted or declined HIV PrEP were compared using Mann-Whitney or χ 2 tests, as appropriate.
A total of 2627 people were tested for HIV: 175 (6.6%) were diagnosed with HIV. Of the 2452 people with negative HIV test results, 2165 (88.3%) were men; median age was 34.3 years (interquartile range = 28.7-42.4). Sexually transmitted infections were detected in 478 of 2452 (19.5%) people, most commonly gonorrhea (206/2452, 8.4%). Overall, 982 of 2452 (40.0%) people accepted PrEP, including only 3 women. Nonacceptance was higher among women ( P < 0.001) and non-White ( P < 0.001). Of those who did not accept PrEP, 260 (17.7%) were diagnosed with at least 1 sexually transmitted infection at the time of HIV testing.
Low PrEP acceptance was observed, particularly among women and people of non-White origin. Nonacceptance of PrEP was also observed among individuals diagnosed with an sexually transmitted infection.
本研究的目的是评估符合预防条件的个体对艾滋病病毒暴露前预防(PrEP)的接受程度。
对在意大利米兰圣拉斐尔科学研究所IRCCS传染病科接受首次艾滋病病毒检测的个体进行回顾性研究。
纳入(1)在2018年1月(意大利可获得PrEP)至2023年12月(数据锁定)期间接受首次艾滋病病毒检测(基线日期)且(2)有基于无保护性行为的PrEP指征的人群;已接受PrEP的人群被排除。根据指南,为艾滋病病毒检测结果为阴性的个体提供PrEP咨询和处方。根据情况,使用曼-惠特尼检验或χ²检验比较接受或拒绝艾滋病病毒PrEP的人群特征。
共有2627人接受了艾滋病病毒检测:175人(6.6%)被诊断为艾滋病病毒感染。在2452名艾滋病病毒检测结果为阴性的人群中,2165人(88.3%)为男性;中位年龄为34.3岁(四分位间距=28.7-42.4)。在2452名人群中有478人(19.5%)检测出性传播感染,最常见的是淋病(206/2452,8.4%)。总体而言,2452名人群中有982人(40.0%)接受了PrEP,其中只有3名女性。女性(P<0.001)和非白人(P<0.001)中的不接受率更高。在未接受PrEP的人群中,260人(17.7%)在艾滋病病毒检测时被诊断出至少感染一种性传播感染。
观察到PrEP的接受率较低,尤其是在女性和非白人中。在被诊断为性传播感染的个体中也观察到对PrEP的不接受情况。